Innovation

Biomarkers of Inflammation in Bruch's Membrane of the Human Retina

Northern Illinois University
posted on 06/24/2010

Age-related macular degeneration (AMD) is a major cause of visual impairment in older adults. Macular degeneration can make it difficult or impossible to read or recognize faces, although enough peripheral vision remains to allow other activities of daily life. The invention herein provides for a method of detecting and diagnosing symptoms of immune-mediated processes during aging and AMD by detecting the biomarkers 3-nitrotyrosine and nitro-A2E within human Bruch’s membrane. The finding of these biomarkers provides the first clear demonstration of non-enzymatic nitration of proteins and age-related deposits (A2E) within human Bruch’s membrane. Either or both biomarkers can be detected using different methods such as a non-invasive fluorescence test or resonance Raman, which is performed with common diagnostic instruments with standard diagnostic techniques. Through the use of these biomarkers and fluorescent patterns, detection of AMD and other diseases such as, but not limited to, cirrhosis, arteriosclerosis, and Alzheimer’s disease can be made earlier, allowing a patient to seek treatment as soon as possible. These biomarkers enable non-invasive monitoring of the progression of the disease, as well.

Suggested Uses

Ophthalmology, detection and treatment of AMD and other diseases

Advantages

Diseases are detected non-invasively and diagnosed earlier, and treatment efficacy is determined easily

Innovation Details
 

Detailed Description

Murdaugh, L.S., Wang, Z., Del Priore, L.V., Dillon, J., Gaillard, E.R. (2010). Age-related accumulation of 3-nitrotyrosine and nitro-A2E in human Bruch’s membrane. Experimental Eye Research. 90 (5), 564-571. Murdaugh, L.S., Dillon, J., Gaillard, E.R. (2009). Modifications to the basement membrane protein laminin using glycolaldehyde and A2E: A model for aging in Bruch’s membrane. Experimental Eye Research. 89 (2), 187-192.

File Number: C09-006 

Disease: Ophthalmology and Optometry


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact NIU TTO at Northern Illinois University for more information.

Request more info via email request more info
People

Case Manager:

NIU TTO NIU TTO

Innovations (30)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

David Kolb, CEO and chairman of the board, Emunamedica LLC.

"We found tremendous value and benefit in using the iBridge Network..."  read more...